Literature DB >> 15741023

Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma.

M Both1, J Schultze, M Reuter, B Bewig, R Hubner, I Bobis, R Noth, M Heller, J Biederer.   

Abstract

PURPOSE: A prospective study to evaluate the diagnostic potential and limitations of three fast MRI sequences in patients with bronchial carcinoma based on the comparison with spiral CT.
MATERIAL AND METHODS: Three fast chest MRI sequences from 20 patients with central or peripheral bronchial carcinoma were evaluated by two observers for relation of tumour to adjacent structures, lymph node enlargement, additional pulmonary lesions and artefacts. The information from MR-imaging was compared with the results from spiral CT. MRI comprised a T1-3D-GRE breath-hold examination ("VIBE", TR/TE 4.5/1.9 ms, flip-angle 12 degrees , matrix 502 x 512, 2.5 mm coronal slices), a breath-hold, T2-HASTE sequence (TR/TE 2000/43 ms, matrix 192 x 256, 10 mm coronal slices) and a respiration-triggered T2-TSE sequence (TR/TE 3000-6000/120 ms, matrix 270 x 512, 6 mm transverse slices). The FOV was adapted individually (380-480 mm).
RESULTS: The presence of the primary bronchial carcinoma and infiltration of thoracic structures by tumour tissue could be demonstrated by all sequences. VIBE sequence was more suitable for detecting small pulmonary nodules than the other MRI examinations, but compared to CT still 20% of these lesions were missed. Contrary to VIBE and T2-weighted TSE scans, HASTE sequence was limited in imaging mediastinal lymph nodes due to missing relevant findings in 2/20 patients. HASTE images significantly provided the lowest rate of artefacts in imaging lung parenchyma (P < 0.001 in peripheral parenchyma), but spatial resolution was limited in this sequence. Concerning the differentiation between tumour and adjacent atelectasis (n = 8), T2-weighted TSE imaging was superior to CT and VIBE in all cases and to HASTE sequence in 4/8 patients.
CONCLUSION: The combination of VIBE and HASTE sequence allows for an adaequate imaging of thoracic processes in patients with bronchial carcinoma, limited only in visualizing small pulmonary nodules. To obtain more detail resolution and to differentiate tumour tissue from adjacent atelectasis, T2-TSE examination may be added in selected cases.

Entities:  

Mesh:

Year:  2005        PMID: 15741023     DOI: 10.1016/j.ejrad.2004.05.007

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.

Authors:  Benedikt Schaarschmidt; Christian Buchbender; Benedikt Gomez; Christian Rubbert; Florian Hild; Jens Köhler; Johannes Grueneisen; Henning Reis; Verena Ruhlmann; Axel Wetter; Harald H Quick; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-08       Impact factor: 9.236

2.  Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects.

Authors:  Hisanobu Koyama; Yoshiharu Ohno; Atsushi Kono; Daisuke Takenaka; Yoshimasa Maniwa; Yoshihiro Nishimura; Chiho Ohbayashi; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

3.  Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis.

Authors:  Iago Pinal-Fernandez; Victor Pineda-Sanchez; Esther Pallisa-Nuñez; Carmen Pilar Simeon-Aznar; Albert Selva-O'Callaghan; Vicente Fonollosa-Pla; Miquel Vilardell-Tarres
Journal:  Clin Rheumatol       Date:  2016-04-23       Impact factor: 2.980

Review 4.  [Role of MRI for detection and characterization of pulmonary nodules].

Authors:  G Sommer; M Koenigkam-Santos; J Biederer; M Puderbach
Journal:  Radiologe       Date:  2014-05       Impact factor: 0.635

Review 5.  [MRI in staging of lung cancer].

Authors:  C Hintze; J Biederer; H W Wenz; R Eberhardt; H U Kauczor
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

6.  Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.

Authors:  Christian Plathow; Michael Klopp; Christian Thieke; Felix Herth; Andreas Thomas; Astrid Schmaehl; Ivan Zuna; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

7.  MRI of the lung (2/3). Why … when … how?

Authors:  J Biederer; M Beer; W Hirsch; J Wild; M Fabel; M Puderbach; E J R Van Beek
Journal:  Insights Imaging       Date:  2012-02-13

8.  MRI of pulmonary nodules: technique and diagnostic value.

Authors:  Juergen Biederer; Christian Hintze; Michael Fabel
Journal:  Cancer Imaging       Date:  2008-05-19       Impact factor: 3.909

9.  MR Imaging of Pulmonary Nodules: Detection Rate and Accuracy of Size Estimation in Comparison to Computed Tomography.

Authors:  Andrzej Cieszanowski; Antonina Lisowska; Marta Dabrowska; Piotr Korczynski; Malgorzata Zukowska; Ireneusz P Grudzinski; Ryszard Pacho; Olgierd Rowinski; Rafal Krenke
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.